Table S1 from Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors
Authors:
- James SpicerJSJames Spicer
- Aurélien MarabelleAMAurélien Marabelle
- Jean-Francois BaurainJBJean-Francois Baurain
- Nina Louise JebsenNJNina Louise Jebsen
- Dag Erik JøssangDJDag Erik Jøssang
- Ahmad AwadaAAAhmad Awada
- Rebecca KristeleitRKRebecca Kristeleit
- Delphine LoiratDLDelphine Loirat
- George LazaridisGLGeorge Lazaridis
- Christiane JungelsCJChristiane Jungels
- Paal BrunsvigPBPaal Brunsvig
- Berit NicolaisenBNBerit Nicolaisen
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)